Merck & Co
Merck & Co is recorded as a service provider in 4 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 4 of 4 trials · Latest update first
A randomized double-masked, multicenter, 3-arm, pivotal Phase 2/3 study to evaluate the efficacy and safety of intravitreal (IVT) EYE201/MK-8748 compared to aflibercept (2 mg) in participants with neovascular age-related macular degeneration (NVAMD)
Sponsor Eyebiotech Limited
- Start (EU)
- Latest update
- Estimated end
A randomized double-masked, multicenter, 3-arm, pivotal Phase 2/3 study to evaluate the efficacy and safety of intravitreal (IVT) EYE201/MK-8748 compared to aflibercept (2 mg) in participants with neovascular age-related macular degeneration (NVAMD)
Sponsor Eyebiotech Limited
- Start (EU)
- Latest update
- Estimated end
A Phase II, Randomized, Double-Blind, PlaceboControlled Study of Ensifentrine in Subjects with Non-Cystic Fibrosis Bronchiectasis
Sponsor Verona Pharma Inc.
- Start (EU)
- Latest update
- Estimated end
A Single Ascending Dose Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1403 in Healthy Male Participants
Sponsor Merck Sharp & Dohme LLC
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Merck & Co?
The 2026-10-09 snapshot links Merck & Co to 4 distinct CTIS trials. Recorded services include Safety reporting & pharmacovigilance, Laboratory services. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Merck & Co?
The most frequently recorded therapeutic areas are Ophthalmology. Recorded phases include Phase 2, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Merck & Co conducted?
The linked trials record locations in 15 countries, including Spain, Italy, Austria, Belgium, Czechia. These are trial locations, not confirmed office locations or countries where Merck & Co delivered services.
What can this page tell me about Merck & Co's trial experience?
Browse 4 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Merck & Co. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Merck & Co. Inc.